Lymphoid malignancies: The dark side of B-cell differentiation

被引:290
作者
Shaffer, AL [1 ]
Rosenwald, A [1 ]
Staudt, LM [1 ]
机构
[1] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nri953
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
When the regulation of B-cell differentiation and activation is disrupted, lymphomas and leukaemias can occur. The processes that normally create immunoglobulin diversity might be misdirected, resulting in oncogenic chromosomal translocations; that block differentiation, prevent apoptosis and/or promote proliferation. Prolonged or unregulated antigenic stimulation might contribute further to the development and progression of some malignancies. Lymphoid malignancies often resemble normal stages of B-cell differentiation, as shown by molecular techniques such as gene-expression profiling. The similarities and differences between malignant and normal B cells indicate strategies for the treatment of these, cancers.
引用
收藏
页码:920 / 932
页数:13
相关论文
共 120 条
  • [1] Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer
    Adams, J
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) : 493 - 500
  • [2] A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue
    Akagi, T
    Motegi, M
    Tamura, A
    Suzuki, R
    Hosokawa, Y
    Suzuki, H
    Ota, H
    Nakamura, S
    Morishima, Y
    Taniwaki, M
    Seto, M
    [J]. ONCOGENE, 1999, 18 (42) : 5785 - 5794
  • [3] Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene
    Akasaka, T
    Akasaka, H
    Ueda, C
    Yonetani, N
    Maesako, Y
    Shimizu, A
    Yamabe, H
    Fukuhara, S
    Uchiyama, T
    Ohno, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 510 - 518
  • [4] Requirement for p27KIP1 in retinoblastoma protein-mediated senescence
    Alexander, K
    Hinds, PW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (11) : 3616 - 3631
  • [5] Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course
    Algara, P
    Mateo, MS
    Sanchez-Beato, M
    Mollejo, M
    Navas, IC
    Romero, L
    Solé, F
    Salido, M
    Florensa, L
    Martínez, P
    Campo, E
    Piris, MA
    [J]. BLOOD, 2002, 99 (04) : 1299 - 1304
  • [6] BCL-6 expression during B-cell activation
    Allman, D
    Jain, A
    Dent, A
    Maile, RR
    Selvaggi, T
    Kehry, MR
    Staudt, LM
    [J]. BLOOD, 1996, 87 (12) : 5257 - 5268
  • [7] Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo
    Angelin-Duclos, C
    Cattoretti, G
    Lin, KI
    Calame, K
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (10) : 5462 - 5471
  • [8] [Anonymous], 2001, Tumours of the Haematopoietic and Lymphoid Tissues
  • [9] CLONING THE CHROMOSOMAL BREAKPOINT OF T(14-18) HUMAN LYMPHOMAS - CLUSTERING AROUND JH ON CHROMOSOME-14 AND NEAR A TRANSCRIPTIONAL UNIT ON 18
    BAKHSHI, A
    JENSEN, JP
    GOLDMAN, P
    WRIGHT, JJ
    MCBRIDE, OW
    EPSTEIN, AL
    KORSMEYER, SJ
    [J]. CELL, 1985, 41 (03) : 899 - 906
  • [10] Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
    Baldwin, AS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) : 241 - 246